The adverse side effects of some medications for hepatitis C can now be observed and studied in laboratory conditions, using petri dishes and test tubes, thanks to the development of a new method by US researchers. A team led by Craig ...
Tags: anti-HCV treatments, hepatitis, disease, PLOS Pathogens
Paragonix Technologies has won Phase I small business innovation research (SBIR) grant from the the National Heart, Blood and Lung Institute for the pre-clinical development of its Paragonix Sherpa cardiac transport system. Single-use, ...
Tags: Paragonix, SBIR grant, pre-clinical development, cardiac transport system
PDS Biotechnology has entered into a licensing agreement with Merck KgaA, Germany, for use of PDS Biotechnology's Versamune nanotechnology platform. Under the terms of the agreement, Merck will obtain the rights to use the technology ...
Tags: Versamune nanotechnology platform, company cooperation
TG Therapeutics and Rhizen Pharmaceuticals have collaborated to develop and commercialise Rhizen PI3K delta inhibitor, TGR-1202 previously referred as RP5264. As part of the collaboration, the companies will develop TGR-1202 on a ...